203 related articles for article (PubMed ID: 32332749)
1. Identification of therapeutics that target eEF1A2 and upregulate utrophin A translation in dystrophic muscles.
Péladeau C; Adam N; Bronicki LM; Coriati A; Thabet M; Al-Rewashdy H; Vanstone J; Mears A; Renaud JM; Holcik M; Jasmin BJ
Nat Commun; 2020 Apr; 11(1):1990. PubMed ID: 32332749
[TBL] [Abstract][Full Text] [Related]
2. The utrophin A 5'-UTR drives cap-independent translation exclusively in skeletal muscles of transgenic mice and interacts with eEF1A2.
Miura P; Coriati A; Bélanger G; De Repentigny Y; Lee J; Kothary R; Holcik M; Jasmin BJ
Hum Mol Genet; 2010 Apr; 19(7):1211-20. PubMed ID: 20053670
[TBL] [Abstract][Full Text] [Related]
3. Identifying FDA-Approved Drugs that Upregulate Utrophin A as a Therapeutic Strategy for Duchenne Muscular Dystrophy.
Péladeau C; Jasmin BJ
Methods Mol Biol; 2023; 2587():495-510. PubMed ID: 36401046
[TBL] [Abstract][Full Text] [Related]
4. Combinatorial therapeutic activation with heparin and AICAR stimulates additive effects on utrophin A expression in dystrophic muscles.
Péladeau C; Ahmed A; Amirouche A; Crawford Parks TE; Bronicki LM; Ljubicic V; Renaud JM; Jasmin BJ
Hum Mol Genet; 2016 Jan; 25(1):24-43. PubMed ID: 26494902
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological activation of PPARbeta/delta stimulates utrophin A expression in skeletal muscle fibers and restores sarcolemmal integrity in mature mdx mice.
Miura P; Chakkalakal JV; Boudreault L; Bélanger G; Hébert RL; Renaud JM; Jasmin BJ
Hum Mol Genet; 2009 Dec; 18(23):4640-9. PubMed ID: 19744959
[TBL] [Abstract][Full Text] [Related]
6. Activation of p38 signaling increases utrophin A expression in skeletal muscle via the RNA-binding protein KSRP and inhibition of AU-rich element-mediated mRNA decay: implications for novel DMD therapeutics.
Amirouche A; Tadesse H; Lunde JA; Bélanger G; Côté J; Jasmin BJ
Hum Mol Genet; 2013 Aug; 22(15):3093-111. PubMed ID: 23575223
[TBL] [Abstract][Full Text] [Related]
7. The utrophin A 5'-untranslated region confers internal ribosome entry site-mediated translational control during regeneration of skeletal muscle fibers.
Miura P; Thompson J; Chakkalakal JV; Holcik M; Jasmin BJ
J Biol Chem; 2005 Sep; 280(38):32997-3005. PubMed ID: 16061482
[TBL] [Abstract][Full Text] [Related]
8. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
9. Drug discovery for Duchenne muscular dystrophy via utrophin promoter activation screening.
Moorwood C; Lozynska O; Suri N; Napper AD; Diamond SL; Khurana TS
PLoS One; 2011; 6(10):e26169. PubMed ID: 22028826
[TBL] [Abstract][Full Text] [Related]
10. Celecoxib treatment improves muscle function in mdx mice and increases utrophin A expression.
Péladeau C; Adam NJ; Jasmin BJ
FASEB J; 2018 Sep; 32(9):5090-5103. PubMed ID: 29723037
[TBL] [Abstract][Full Text] [Related]
11. Utrophin A is essential in mediating the functional adaptations of mdx mouse muscle following chronic AMPK activation.
Al-Rewashdy H; Ljubicic V; Lin W; Renaud JM; Jasmin BJ
Hum Mol Genet; 2015 Mar; 24(5):1243-55. PubMed ID: 25324540
[TBL] [Abstract][Full Text] [Related]
12. Alternative utrophin mRNAs contribute to phenotypic differences between dystrophin-deficient mice and Duchenne muscular dystrophy.
Perkins KJ; Davies KE
FEBS Lett; 2018 Jun; 592(11):1856-1869. PubMed ID: 29772070
[TBL] [Abstract][Full Text] [Related]
13. Identification of FHL1 as a therapeutic target for Duchenne muscular dystrophy.
D'Arcy CE; Feeney SJ; McLean CA; Gehrig SM; Lynch GS; Smith JE; Cowling BS; Mitchell CA; McGrath MJ
Hum Mol Genet; 2014 Feb; 23(3):618-36. PubMed ID: 24087791
[TBL] [Abstract][Full Text] [Related]
14. Embryonic myosin is a regeneration marker to monitor utrophin-based therapies for DMD.
Guiraud S; Edwards B; Squire SE; Moir L; Berg A; Babbs A; Ramadan N; Wood MJ; Davies KE
Hum Mol Genet; 2019 Jan; 28(2):307-319. PubMed ID: 30304405
[TBL] [Abstract][Full Text] [Related]
15. IRES-mediated translation of utrophin A is enhanced by glucocorticoid treatment in skeletal muscle cells.
Miura P; Andrews M; Holcik M; Jasmin BJ
PLoS One; 2008 Jun; 3(6):e2309. PubMed ID: 18545658
[TBL] [Abstract][Full Text] [Related]
16. Utrophin influences mitochondrial pathology and oxidative stress in dystrophic muscle.
Kennedy TL; Moir L; Hemming S; Edwards B; Squire S; Davies K; Guiraud S
Skelet Muscle; 2017 Oct; 7(1):22. PubMed ID: 29065908
[TBL] [Abstract][Full Text] [Related]
17. Sarcospan integration into laminin-binding adhesion complexes that ameliorate muscular dystrophy requires utrophin and α7 integrin.
Marshall JL; Oh J; Chou E; Lee JA; Holmberg J; Burkin DJ; Crosbie-Watson RH
Hum Mol Genet; 2015 Apr; 24(7):2011-22. PubMed ID: 25504048
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of brain utrophin does not rescue behavioral alterations in dystrophin-deficient mice.
Perronnet C; Chagneau C; Le Blanc P; Samson-Desvignes N; Mornet D; Laroche S; De La Porte S; Vaillend C
Hum Mol Genet; 2012 May; 21(10):2263-76. PubMed ID: 22343141
[TBL] [Abstract][Full Text] [Related]
19. Cis-Acting Sequence Elements and Upstream Open Reading Frame in Mouse Utrophin-A 5'-UTR Repress Cap-Dependent Translation.
Ghosh T; Basu U
PLoS One; 2015; 10(7):e0134809. PubMed ID: 26230628
[TBL] [Abstract][Full Text] [Related]
20. Utrophin upregulation in Duchenne muscular dystrophy.
Hirst RC; McCullagh KJ; Davies KE
Acta Myol; 2005 Dec; 24(3):209-16. PubMed ID: 16629055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
